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Abstract Kawasaki disease (KD) is an acute febrile dis-
ease of unknown etiology that develops in children and is
sometimes accompanied by myocardial dysfunction and
systemic vasculitis. However, myocardial repolarization
lability has not yet been fully investigated. Thus, the
objective of this study was to evaluate myocardial repo-
larization lability (QT variability index—QTVI) based on
the body surface electrocardiograms in the acute and
recovery phases. The subjects were 25 children with acute
KD who were hospitalized for treatment. An equal number
of age-matched healthy children were selected as con-
trols.The RR-intervals and QT-intervals were measured
based on a body surface electrocardiogram of 120 consec-
utive heartbeats to calculate the QTVI. The QTVI values
were then compared with the acute and recovery phases.
The relationships between blood biochemistry data and
QTVI values were also examined. QTVI was signiﬁcantly
decreased from the acute phase to the recovery phase
(P\0.05) and then recovered to the same level as that of
the control. QTVI in the acute phase showed a signiﬁcant
positive relationship with body temperature and C-reactive
protein (P\0.05). QTVI was high in the acute phase and
was correlated with an inﬂammatory reaction and became
normalized during the recovery phase.
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Introduction
Kawasaki disease (KD) is an acute febrile disease of
unknown etiology that develops in children. Recently, the
incidence of KD has reached[10,000 cases/year in Japan.
There have been some cases of systemic vasculitis and
myocardial dysfunction as a consequence of this disease.
Dilatation of the coronary artery has also been observed,
although the incidence is low. It has been shown that insta-
bility of myocardial repolarization is increased because of
ischemic myocardial failure in patients with coronary arte-
rial aneurysm as complications [1, 2]. Therefore, the evalu-
ation of myocardial failure, including proarrhythmic
substrate in the acute phase, could be important for under-
standing the pathophysiology of KD. To date, no compara-
tive study on alterations of myocardial repolarization from
the acute phase to the recovery phase of KD has been
reported. Thus, the lability of myocardial repolarization
accompanied by inﬂammation remains unknown. The
objectives of this study were to compare the QT variability
index (QTVI) [3] in the acute phase of KD and in the
recovery phase after treatment with immunoglobulin based
on a body surface ECG. We also investigated correlations
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evaluated the instability of myocardial repolarization.
Subjects
The subjects were 30 children with KD who were hospi-
talized at Fujita Health University Hospital and Toyokawa
Municipal Hospital. After the diagnosis was made, all
patients had fulﬁlled the American Heart Association
guidelines for diagnosis of KD and received intravenous
immunoglobulin (2 g/kg) treatment (5.2 ± 0.8 days after
the onset of fever). In addition, aspirin was given at a dose
of 50 mg/kg/d for the ﬁrst 5–10 days and was followed by
a lower antiplatelet dose (5 mg/kg) for the next 4–6 weeks.
For the present analysis, three patients were excluded
because stable electrocardiogram (ECG) recordings were
not possible due to vigorous motion and crying. An addi-
tional two patients were excluded because they showed
extremely high heart rates (HRs;[180 bpm) with over-
lapping of T-wave terminal portion and P wave. Finally, 25
patients (16 boys and 9 girls; age 2.2 ± 2.1 years) were
included in this study. The average febrile period was
7.5 ± 2.5 days; the average body temperature was
37.9C ± 1.1C at the time of ECG the acute phase; and
the average hospitalization period was 15.5 ± 5.0 days.
The Z score (SD C? 2.5 was determined to be signiﬁcant)
[4] was used for the evaluation of coronary artery ectasia.
Although transient coronary artery abnormalities were
observed during the course of the disease in four patients,
all patients were discharged from hospital with no com-
plications, including coronary artery aneurysm. An equal
number of healthy children (age 2.2 ± 0.4 years), who
were age- and sex-matched comparably to the subjects,
were used as controls. This study was approved by our
institution’s Ethics Committee.
Methods
After obtaining written informed consent from parents,
electrocardiography (CM5-lead) was conducted during
cardiac ultrasonography using a biopolygraph MP-150
(Biopac Systems, Goleta, CA). Pretreatment with sodium
trichloroethyl phosphate syrup (0.7 ml/kg) was conducted
for tranquilization in children age 3–12 months. The RR-
interval was automatically recorded based on the original
electrocardiographic data of 120 consecutive heartbeats
(which showed no arrhythmia and no overlapping of the
terminal portion of the T-wave and the ascending limb of
the P-wave) using Acqknowledge version 3.9 (Biopac
Systems). The starting point of the Q waves and the end of
the T waves were determined by linear derivation and the
absolute values to measure the RR- and QT-intervals of the
same heartbeats. The instantaneous HR was determined
based on the measured RR-intervals to calculate the mean
HR (HRm) and variance of HR (HRv) of the 120 heart-
beats. The mean QT-interval (QTm) and variance of
the QT-interval (QTv) were determined based on the
QT-intervals of the same heartbeats to compare the QTVI in
the acute (7.2 ± 0.7 days) and recovery (22.0 ± 4.1 days)
phases using the formula described by Berger et al. [3]
(Eq. 1):
QTVI ¼ Log10 QTv=QTm2 
= HRv=HRm2  
: ð1Þ
The relationships between blood biochemistry data at
the time of hospitalization and QTVI values and those
between body temperature and QTVI values were
analyzed. Serum chemistry examinations were conducted
for white blood cell count (WBC), neutrophils, hematocrit,
platelets, C-reactive protein (CRP), total protein, albumin,
sodium, potassium, chloride, aspartate transaminase (AST),
alanine transaminase (ALT), and total bilirubin. None of
the patients required treatment, such as administration of
catecholamine, diuretics, etc., for heart failure, and no
agents that might have affected the QT-interval were
administered. For statistical analysis, JMP statistical
analysis software version 5.1.2 (SAS Cary, NC) was
used. Paired Student t test was conducted to compare the
blood biochemistry data and ECG parameters of acute and
recovery phases, and Pearson’s correlation coefﬁcients
analysis was conducted for CRP, body temperature and
QTVI in acute phase. Tukey-Kramer Honestly Signiﬁcant
Difference test was used to compare the QTVI of KD
patients with that in healthy children. A p value\0.05 was
considered to be signiﬁcant.
Results
Comparison of ECG Parameters
No signiﬁcant differences were found in mean RR-interval,
variance of RR-interval, and variance of HR, whereas
signiﬁcant differences were observed in the variance of
QT-interval between the acute and recovery phases
(Table 1).
Comparison of QTVI Values in the Acute
and Recovery Phases
QTVIwassigniﬁcantlydecreasedfromtheacutephasetothe
recovery phase (–0.60 ± 0.54 to –1.22 ± 0.31, p\0.05)
and was then restored to a value equivalent to that of the
healthy controls (Fig. 1). Figure 2 shows typical ECG pat-
terns from a patient in the acute and recovery phases.
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There were signiﬁcant differences in WBC, hematocrit,
sodium, total protein, albumin, and CRP between the acute
and recovery phases (Table 2). There were no signiﬁcant
differences in platelets, potassium, chloride, total bilirubin,
AST, and ALT between the acute and recovery phases.
Pearson’s correlation coefﬁcients of CPR and QTVI values
in the acute phase showed a signiﬁcant positive correlation
(r = 0.404; Fig. 3).
Body Temperature and QTVI Values
Pearson’s correlation coefﬁcients of body temperature and
QTVI values in the acute phase showed a signiﬁcant
positive correlation (r = 0.607; Fig. 4), and QTVI
increased in accordance with increased body temperature.
Discussion
The etiology of KD has not been clariﬁed to date,[40 years
after its discovery. However, with regard to the etiology of
this disease, overproduction of inﬂammatory cytokines is
believed to cause myocarditis or a lesion in the coronary
artery [5, 6]. However, sufﬁcient clariﬁcation of the elec-
trophysiological changes due to inﬂammation in the acute
phase has not yet been achieved. Thus, in the current study,
we calculated QTVI based on a noninvasive body surface
ECG to assess abnormal myocardial repolarization in the
acute phase.
The QTVI used in this study is a new index reﬂecting
instability of repolarization of the ventricular myocardium,
which is calculated based on a single-lead body surface
ECG and represents the log ratio between the QT interval
and HR variability, each normalized by the squared mean
of process. This index has been reported to be high in
patients with dilated cardiomyopathy [7, 8], in those at
risk for fatal arrythmias, and in those with hypertrophic
cardiomyopathy [9].
In this study, we found that QTVI was signiﬁcantly
increased in the acute phase compared with the recovery
phase. Furthermore, QTVI was restored to the same level as
thatofhealthy controlsinthe recoveryphase.Withregardto
the relationship between body temperature and blood bio-
chemistry data in our patients, QTVI index had a signiﬁcant
positive correlation with body temperature and CRP. Based
on these ﬁndings, we speculated that the onset of fever
causedbythereleaseofvariouscytokinesandCRP,whichis
closely related to interleukin (IL)-6, strongly affected myo-
cardial repolarization in the acute phase of KD [5, 6].
Because HR generally increases in accordance with the
onset of fever, catecholamines are considered to affect HR
directly and QTVI is thought to be increased by augmented
sympathetic nerve activity in patients with heart failure
[10]. However, recent ﬁndings have shown that there is no
correlation between serum concentrations of norepineph-
rine, which activates the sympathetic nervous system, and
QTVI in patients without heart failure; [11] i.e., the sub-
jects were children without heart failure, and the increased
QTVI observed in the acute phase was not considered to
depend on sympathetic tone caused by the onset of fever
but rather on the inﬂammatory humoral regulators descri-
bed previously. Similarly, increased cytokines such as
tumor necrosis factor-alpha and IL-6, which cause systemic
inﬂammation, have been reported in the acute phase of KD
[12, 13]. Furthermore, recent reports of in vitro studies
have indicated alterations in ionic currents by cytokines,
Table 1 Comparison of ECG parameters in the acute and recovery
phases
Parameters Acute phase Recovery phase p
RRm (ms) 525.3 ± 97.6 530.8 ± 53.8 0.770
RRv (ms) 940.3 ± 471.2 721.6 ± 502.1 0.473
HRm (ms) 118.4 ± 22.1 114.4 ± 11.4 0.355
HRv (ms) 31.2 ± 40.2 32.9 ± 26.7 0.803
QTm (ms) 301.2 ± 39.3 304.8 ± 23.9 0.593
QTv (ms) 39.5 ± 46.3
a 13.0 ± 7.8 \0.05
QTcB (ms) 416.6 ± 26.6 419.2 ± 23.7 0.598
QTcF (ms) 375.3 ± 29.9 376.8 ± 22.6 0.763
QTVI –0.60 ± 0.54
a -1.22 ± 0.31 \0.05
QTcB = Corrected QT Interval by Bazett formula; QTcF = Corrected
QT Interval by Fridericia formula
a Value expressed as the mean ± SD (p\0.05)
p <0.05  N.S. 
p <0.05 
Q
T
V
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Fig. 1 Comparison of QTVI values in the acute and recovery phases
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123which are responsible for myocardial action potentials
[14, 15]. Based on the results of our study, we also believe
that myocardial repolarization was altered by humoral
regulators, such as cytokines, in the febrile phase, when an
inﬂammatory reaction was strong in children affected with
KD. Only sporadic premature ventricular contractions were
observed, and no serious arrhythmias, such as fever-
induced ventricular tachycardia [16], were observed in this
study, but these arrhythmias may be related not only to a
prolonged myocardial repolarization time but also insta-
bility of the ionic current and the refractory period of
action potential [17, 18]. However, QTVI can stratify the
risk of arrhythmogenesis caused by inﬂammation even
when there is no cardiac channelopathy, and electrophys-
iological evaluation of the myocardium using this method
is considered to be useful for patients such as children, in
whom invasive examinations including coronary angiog-
raphy, exercise stress, and myocardial scintigram are
restricted. Further prospective larger-scale studies are
Fig. 2 Comparison of QTVI
values between acute and
recovery phases in a typical
case. Four to 6 of the 120
measured heartbeats are shown
as representative heartbeats
Table 2 Comparison of blood biochemistry data in the acute and
recovery phases
Biochemistry data Acute phase Recovery phase p
WBC (10
2/mm
3) 127.3 ± 57.3
a 83.9 ± 34.5 \0.05
Hematocrit (%) 32.1 ± 4.0
a 34.4 ± 2.9 \0.05
Platelet (10
4/mm
3) 42.0 ± 17.1 44.3 ± 20.6 0.672
Total bilirubin (mg/dl) 0.5 ± 0.4 0.4 ± 0.1 0.508
AST (IU/l) 40.0 ± 25.9 40.0 ± 17.2 0.995
ALT (IU/l) 28.4 ± 26.8 19.0 ± 13.0 0.132
Sodium (mmol/l) 134.7 ± 2.9
a 137.2 ± 1.7 \0.05
Potassium (mmol/l) 4.7 ± 0.6 4.6 ± 0.5 0.295
Chloride (mmol/l) 99.4 ± 4.0
a 101.8 ± 1.2 \0.05
Total protein (g/dl) 7.5 ± 1.1
a 8.1 ± 0.7 \0.05
Albumin (g/dl) 3.3 ± 0.6
a 4.0 ± 0.4 \0.05
CRP (mg/dl) 5.7 ± 3.6
a 0.3 ± 0.1 \0.05
a Value expressed as mean ± SD (p\0.05)
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Fig. 3 CRP versus QTVI. CRP and QTVI values in the acute phase
showed a signiﬁcant positive linear correlation (r = 0.404,
p = 0.045)
-2 
-1.5 
-1 
-0.5 
0
0.5
1
36 37 38 39 40
BT  
Q
T
V
I
 
Fig. 4 Body temperature (C) versus QTVI. Body temperature and
QTVI showed a signiﬁcant positive correlation in the acute phase
(r = 0.607, p = 0.0001)
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123needed to prove that QTVI can be a predictor of lethal
arrhythmias.
Study Limitations
Using the current methods, it was difﬁcult to analyze the
QT-interval automatically, based on the record of over-
lapping the terminal portion of the T wave and the
ascending limb of the P wave when the HR s exceeded
180 bpm.
Conclusion
We conducted a comparative investigation of the charac-
teristics of myocardial repolarization in the acute and
recovery phases of KD based on QTVI values. We showed
that QTVI was high and that the lability of myocardial
repolarization was increased in the acute phase, indicating
the involvement of humoral regulators, which were
reﬂected by the fever and CRP. Although arrythmogenesis
may not be evident, subclinical ventricular repolarization
lability may be present (and is independent of coronary
artery involvement). Further studies may be warranted to
clarify the mechanisms underlying ventricular repolariza-
tion lability and elucidate the relationships between
arrhythmogenesity and inﬂammation of KD.
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